Literature DB >> 26535034

Perspectives of tissues in silico.

Seddik Hammad1, Mosaab A Omar2, Mohammed F Abdallah3, Hassan Ahmed4.   

Abstract

Entities:  

Year:  2015        PMID: 26535034      PMCID: PMC4614268          DOI: 10.17179/excli2015-219

Source DB:  PubMed          Journal:  EXCLI J        ISSN: 1611-2156            Impact factor:   4.068


× No keyword cloud information.

‬‬‬‬

Over the past decade much effort has been invested into the development of in vitro systems as alternatives to animal experiments (Hammad et al., 2013[15], 2014[12]; Hammad, 2013[11]; Godoy et al., 2010[9], 2013[8]; Hewitt et al., 2007[17]; Stewart and Marchan, 2012[25]; Gebel et al., 2014[6]; Grinberg et al., 2014[10]). However, in vitro systems still have the limitation that they often do not sufficiently represent the in vivo situation. Moreover, quantitative in vitro to in vivo extrapolation is difficult (Ghallab, 2013[7]; Reif, 2014[21]; Stewart, 2010[24]). In recent years a concept is emerging that may overcome many of the current limitations of in vitro testing, namely in silico tissues (Hoehme et al., 2010[18]; Schliess et al., 2014[22]). Typically, virtual tissues are based on reconstructions of real tissues, where the exact positions of each individual cell and further relevant structures, e.g. blood vessels, are known in a three-dimensional space (Hoehme et al., 2010[18]; Höhme et al., 2007[19]). In the first step spatio-temporal models are generated from reconstructions (Hammad et al., 2014[14]). For this purpose the individual cell serves as the smallest unit. Model parameters, such as the probability to divide or to die, and even more complex properties, such as migration rules can be programmed into each cell. This results in a model that can simulate, for example, the spatio-temporal process of tissue damage and regeneration. Key principles how cells in the liver coordinately respond to large destructions to restore functional tissue have been identified by such models (Drasdo et al., 2014[3]; Hoehme et al., 2010[18]). In next steps, further processes can be integrated into spatio-temporal models, e.g. blood flow or metabolic processes. As an example, Schliess et al. (2014[22]) have integrated metabolic pathway models of ammonia detoxification into spatio-temporal models. This allows simulating ammonia concentrations in the blood circulation and how they are influenced by specific damage patterns of the liver. In toxicology, modelling especially structure activity and physiologically-based-pharmacokinetic (PBPK) models have a long standing tradition (Schug et al., 2013[23]; Karamanakos et al., 2009[20]; Carlsson et al., 2004[1]; Thiel et al., 2015[26]; Hammad and Ahmed, 2014[13]; Dobrev et al., 2001[2]; El-Masri et al., 1996[5]). However, the advent of spatio-temporal models with the possibility to integrate other model types opens new possibilities. Integrated mathematical models formalize the relationship between individual components to test their interactions in a virtual setting (Drasdo et al., 2014[3][4]; Widera, 2014[27]). It can be expected that virtual tissue approaches will have a strong impact to understand complex pathophysiologies, especially when processes and interactions have to be elucidated that cannot be directly measured by established methods.
  20 in total

1.  Prediction and validation of cell alignment along microvessels as order principle to restore tissue architecture in liver regeneration.

Authors:  Stefan Hoehme; Marc Brulport; Alexander Bauer; Essam Bedawy; Wiebke Schormann; Matthias Hermes; Verena Puppe; Rolf Gebhardt; Sebastian Zellmer; Michael Schwarz; Ernesto Bockamp; Tobias Timmel; Jan G Hengstler; Dirk Drasdo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-19       Impact factor: 11.205

Review 2.  Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies.

Authors:  Nicola J Hewitt; María José Gómez Lechón; J Brian Houston; David Hallifax; Hayley S Brown; Patrick Maurel; J Gerald Kenna; Lena Gustavsson; Christina Lohmann; Christian Skonberg; Andre Guillouzo; Gregor Tuschl; Albert P Li; Edward LeCluyse; Geny M M Groothuis; Jan G Hengstler
Journal:  Drug Metab Rev       Date:  2007       Impact factor: 4.518

Review 3.  Manufactured nanomaterials: categorization and approaches to hazard assessment.

Authors:  Thomas Gebel; Heidi Foth; Georg Damm; Alexius Freyberger; Peter-Jürgen Kramer; Werner Lilienblum; Claudia Röhl; Thomas Schupp; Carsten Weiss; Klaus-Michael Wollin; Jan Georg Hengstler
Journal:  Arch Toxicol       Date:  2014-10-19       Impact factor: 5.153

4.  A systematic evaluation of the use of physiologically based pharmacokinetic modeling for cross-species extrapolation.

Authors:  Christoph Thiel; Sebastian Schneckener; Markus Krauss; Ahmed Ghallab; Ute Hofmann; Tobias Kanacher; Sebastian Zellmer; Rolf Gebhardt; Jan G Hengstler; Lars Kuepfer
Journal:  J Pharm Sci       Date:  2014-11-12       Impact factor: 3.534

5.  Assessing interaction thresholds for trichloroethylene in combination with tetrachloroethylene and 1,1,1-trichloroethane using gas uptake studies and PBPK modeling.

Authors:  I D Dobrev; M E Andersen; R S Yang
Journal:  Arch Toxicol       Date:  2001-05       Impact factor: 5.153

6.  Physiologically based pharmacokinetic/pharmacodynamic modeling of the toxicologic interaction between carbon tetrachloride and Kepone.

Authors:  H A el-Masri; R S Thomas; G R Sabados; J K Phillips; A A Constan; S A Benjamin; M E Andersen; H M Mehendale; R S Yang
Journal:  Arch Toxicol       Date:  1996       Impact factor: 5.153

7.  Integrated metabolic spatial-temporal model for the prediction of ammonia detoxification during liver damage and regeneration.

Authors:  Freimut Schliess; Stefan Hoehme; Sebastian G Henkel; Ahmed Ghallab; Dominik Driesch; Jan Böttger; Reinhard Guthke; Michael Pfaff; Jan G Hengstler; Rolf Gebhardt; Dieter Häussinger; Dirk Drasdo; Sebastian Zellmer
Journal:  Hepatology       Date:  2014-05-12       Impact factor: 17.425

8.  Olfactory mucosal toxicity screening and multivariate QSAR modeling for chlorinated benzene derivatives.

Authors:  Carina Carlsson; Mikael Harju; Fariba Bahrami; Tatiana Cantillana; Mats Tysklind; Ingvar Brandt
Journal:  Arch Toxicol       Date:  2004-11-05       Impact factor: 5.153

9.  Concepts of predictive toxicology.

Authors:  Raymond Reif
Journal:  EXCLI J       Date:  2014-12-18       Impact factor: 4.068

10.  Biomarker: the universe of chemically induced gene expression alterations in human hepatocyte.

Authors:  Seddik Hammad; Hassan Ahmed
Journal:  EXCLI J       Date:  2014-12-09       Impact factor: 4.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.